NeoChord is now training 20 US centers in preparation for a US randomized clinical trial to support a PMA for its NeoChord DS1000 artificial chordae delivery system for minimally invasive mitral valve repair.
The NeoChord DS1000 is a tool for the transapical delivery of expanded polytetrafluoroethylene sutures to replace damaged chordae tendinae –...





